Search Results - "Crombet, T"

Chronic vaccination with a therapeutic EGF-based cancer vaccine: a review of patients receiving long lasting treatment by Gonzalez, G, Crombet, T, Lage, A

“…Therapeutic vaccines continue to be one of the most active fields in cancer research. However, despite clear evidence of antitumor effect in laboratory…”
Get more information

Efficacy of racotumomab or nimotuzumab vs docetaxel as second-line therapy for advanced non-small cell lung cancer patients by Hernandez, M., Neninger, E., Santiesteban, E., Camacho, K., Hernandez, N., Amador, R., Acosta, S., Gonzalez, Y., Jimenez, Y., Corella, M., Ortiz, R.A., Bello, L., Calana, A., Pichs, G., Cala, M., Flores, Y., Viada, C., Robaina, M., Crombet, T.

Get full text

536 RANIDO trial: Racotumomab-alum vaccine, Nimotuzumab or Docetaxel as switch maintenance therapy for advanced NSCLC by Hernandez, M, Neninger, E, Santiesteban, E, Ortiz, R, Amador, R, Bello, L, Acosta, S, Flores, Y, Cala, M, Martínez, O, Calana, A, Pichs, G, Robaina, M, Sánchez, L, Viada, C, Valdez, A, Mendoza, I, Guerra, P, Crombet, T

Get full text

Invariance of Quality of Life Questionnaire Eortc Qlqc30 In Different Cancer Indications by Viada, C, Ballesteros, J, Fors, M, Luaces, P, Sanchez, L, Alvarez, M, Frias, A, Crombet, T

Get full text

A Proposed 6-Item Reduction for the European Organization for the Research and Treatment of Cancer-Quality of Core Questionnaire (EORTC QLQ-C30) - Cuban Group of Trialists on Epidermal Growth Factor (CGT-EGF) by Viada, C, Ballesteros, J, Fors, M, Luaces, P, Sánchez, L, Crombet, T

Get full text

Epidermal growth factor-based cancer vaccine for non-small-cell lung cancer therapy by Gonzalez, G., Crombet, T., Torres, F., Catala, M., Alfonso, L., Osorio, M., Neninger, E., Garcia, B., Mulet, A., Perez, R., Lage, R.

“…Background: The role that growth factors and their receptors play in human cancer growth and progression makes them interesting targets for novel treatment…”
Get full text

Estimating and Modeling Long Term Survival in Lung Cancer Using Mixture Parametric Models by Sánchez, L, Luaces, P, Viada, C, Galan, Y, Ballesteros, J, Rodríguez, P.C, Crombet, T, Lage, A

Get full text

Threshold Selection in Biomarkers Using Cox Regression. An Application to Non-Small-Cell Lung Cancer by Luaces, P, Sánchez, L, Ballesteros, J, García, B, Rodríguez, P.C, Viada, C, Popa, X, Crombet, T, Lage, A

Get full text

PO-486 Surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimised EGF-based vaccination schedule by Mazorra, Z, Popa, X, Garcia, B, Huerta, V, Viada, CE, Neninger, E, Rodriguez, PC, Gonzalez, Z, Gonzalez, A, Crombet, T

“…IntroductionIn previous clinical trials were reported that an EGF-based vaccine administration was immunogenic in advanced non-small cell lung cancer (NSCLC)…”
Get full text

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial by González, G., Crombet, T., Catalá, M., Mirabal, V., Hernández, J. C., González, Y., Marinello, P., Guillén, G., Lage, A.

“…Background: There is evidence of a relationship between epidermal growth factor (EGF) and tumor cell proliferation, such as the overexpression of EGF receptor…”
Get full text

Systematization of the vesical and uterovaginal efferences of the female inferior hypogastric plexus (pelvic) : applications to pelvic surgery on women patients by MAUROY, B, BIZET, B, BONNAL, J. L, CROMBET, T, DUBURCQ, T, HURT, C

“…To locate and describe the various efferences of the plexus in order to make it easier to avoid nerve lesions during pelvic surgery on women patients through a…”
Get full text

Diagnostic efficacy and safety of 99mTc-Labeled monoclonal antibody ior c5 in patients with colorectal and anal carcinomas: Final report clinical trial phase I/II by Ramos-Suzarte, Mayra, Perera Pintado, Alejandro, Mesa, Nelson Rodríguez, Oliva, Juan P., Iznaga-Escobar, Normando, Aroche, Leonel T., Pimentel, Gilmara, González, Joaquín, Cordero, Maria, Rodríguez, Obaya T., Crombet, Ramos T., Perez, R.

“…Monoclonal antibody (mAb) ior c5 is an IgG 1 , which recognizes a glycoprotein tumor specific antigen IOR C2 over expressed in the surface of colon and ovarian…”
Get full text

1249 Combination of platinum standard first front line chemotherapy and anti-idiotype 1E10/aluminum vaccine in patients with advanced non- small- cell lung cancer (NSCLC) by Macias, A, Toledo, D, Santiesteban, E, Aguirre, F, Popa, X, Vazquez, A, Mazorra, Z, Crombet, T, Perez, R

Get full text

8711 Nimotuzumab and radiotherapy in children and adolescents with brain stem glioma: preliminary results from a Phase II study by Crombet, T, Cabanas, R, Alert, J, Valdés, J, González, M.C, Pedrayes, J.L, Ríos, M, Leyva, T, Herrera, R, Avila, M

Get full text

857O MACH-EGFR: Individual patient data (IPD) meta-analysis of anti-EGFR monoclonal antibodies (Ab) in patients (pts) with locally advanced (LA) squamous cell carcinomas of head and neck (SCCHN) by Blanchard, P., Cheugoua-Zanetsie, M., Deneche, I., Rosenthal, D.I., Gillison, M., Eriksen, J.G., Prabhash, K., Giralt, J., Bonner, J.A., Ghi, M.G., Mehanna, H., Siu, L.L., Gebre Medhin, M., Rischin, D., Dietz, A., Mesia Nin, R., Pointreau, Y., Crombet, T., Auperin, A.

Get full text

Optimization of cancer vaccination schedule looking for better responses to EGF vaccine in NSCLC patients by Garcia, B, Neninger, E, Pereda, S, Leonard, I, Gonzalez, G, Mazorra, Z, Lage, A, Crombet, T

Get full text

505 POSTER Preliminary results of a phase II clinical trial of the anti EGFR monoclonal antibody Nimotuzumab in combination with whole brain radiation therapy in patients diagnosed with advanced non-small cell lung cancer tumors unresectable brain metastases by Macias, A, Neninger, E, Santiesteban, E, Figueredo, J, Hernandez, A, Aguirre, F, Aguilera, N, Crombet, T

Get full text

Correcting for Switching to Second Line Treatment in the Survival Analysis: An Example of the Use of Inverse Probability of Censoring Weighted Analysis by Sanchez, L, Luaces, P, Crombet, T

Get full text

PRM212 - Correcting for Switching to Second Line Treatment in the Survival Analysis: An Example of the Use of Inverse Probability of Censoring Weighted Analysis by Sanchez, L, Luaces, P, Crombet, T

Get full text

802 POSTER Epidermal Growth Factor (EGF) based cancer vaccine for NSCLC: immunological evaluation and impact on the EGFR signal transduction cascade by Crombet, T, García, B, Neninger, E, Catalá, M, Torre, A, Leonard, I, Martínez, R, Mazorra, Z, González, G, Lage, A

Get full text